September 02, 2014 10:17 AM ET

Healthcare Providers and Services

Company Overview of Labco S.A.S.

Company Overview

Labco S.A.S., a medical diagnostics company, owns and operates a pan-European network of local and regional clinical laboratories. Its laboratories provide physicians and patients with a portfolio of tests in clinical chemistry, hematology, immunology, microbiology, parasitology, pathology, serology, toxicology, virology, genetic testing, and other fields. The company, through a joint venture, also offers laboratory outsourcing services to hospitals and other healthcare organizations in the United Kingdom. Labco S.A.S. was founded in 2003 and is based in Paris, France. It has laboratory locations in France, Spain, Portugal, Germany, Belgium, Italy, and the Netherlands. The company also has o...

60-62, rue d'Hauteville

Paris,  75010


Founded in 2003


33 1 56 02 36 81


33 1 56 02 36 82

Key Executives for Labco S.A.S.

Chief Executive Officer
Age: 48
Co-Founder and Vice President of France
Chief Financial Officer
Group Chief Information Officer and Vice President of Organization & Information Technology
Vice President of Marketing & Sales and Head of European Development
Compensation as of Fiscal Year 2014.

Labco S.A.S. Key Developments

Labco S.A.S. Presents at Bank of America Merrill Lynch European High-Yield Healthcare Conference, May-21-2014 10:00 AM

Labco S.A.S. Presents at Bank of America Merrill Lynch European High-Yield Healthcare Conference, May-21-2014 10:00 AM. Venue: Connaught Hotel, London, United Kingdom. Speakers: Vincent Marcel, Chief Financial Officer.

Labco S.A.S. Changes Corporate Form of the Issuer

On January 12, 2012, Labco S.A.S., a private limited liability company (société par actions simplifiée) converted its corporate form into a société anonyme. References to Labco S.A.S. in the name of the Issuer have now changed to Labco S.A.

Labco S.A Raises EUR 100 Million in Private Placement of Senior Notes

Labco S.A., has completed a private placement of EUR 100 million in aggregate principal amount of its 8.5% senior secured notes due 2018. Kirkland & Ellis International LLP acted as legal advisor to the company. The notes constitute a further issuance of, and will form a single class with, Labco's existing 8.5% senior secured notes due 2018. The notes are being offered only to qualified institutional buyers and will mature on January 15, 2018.

Similar Private Companies By Industry

Company Name Region
Breas Médical SARL Europe
Camille Blanc d'Evian Europe
Clinique Saint Privât Europe
Clinique de la Roseraie SAS Europe

Recent Private Companies Transactions

July 31, 2014
SDN Istituto di Ricerca Diagnostica e Nucleare
January 28, 2014
Centre Immunològic de Catalunya SA
September 26, 2013
Labco S.A.S., German Laboratory Business

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Labco S.A.S., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at